IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,602,000 | +19.2% | 63,707 | 0.0% | 0.88% | -1.3% |
| Q3 2020 | $3,023,000 | -19.5% | 63,707 | 0.0% | 0.90% | -28.5% |
| Q2 2020 | $3,756,000 | +9.9% | 63,707 | -11.8% | 1.25% | -12.6% |
| Q1 2020 | $3,417,000 | -16.1% | 72,267 | +7.2% | 1.44% | +0.1% |
| Q4 2019 | $4,074,000 | +10.5% | 67,433 | +8.0% | 1.43% | +2.1% |
| Q3 2019 | $3,688,000 | +138.9% | 62,434 | +161.6% | 1.40% | +148.2% |
| Q2 2019 | $1,544,000 | +25.9% | 23,866 | 0.0% | 0.57% | +4.2% |
| Q1 2019 | $1,226,000 | 0.0% | 23,866 | 0.0% | 0.54% | +3.6% |
| Q4 2018 | $1,226,000 | -0.7% | 23,866 | 0.0% | 0.52% | +23.6% |
| Q3 2018 | $1,235,000 | +23.3% | 23,866 | 0.0% | 0.42% | +14.3% |
| Q2 2018 | $1,002,000 | -4.8% | 23,866 | 0.0% | 0.37% | -14.3% |
| Q1 2018 | $1,052,000 | – | 23,866 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |